1. India Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Medico Remedies Limited

Medico Remedies Limited

MEDICO.BO
Medico Remedies LimitedIN flagBombay Stock Exchange
40.39
INR
-0.61
- -
3.37BMarket Cap

Total Valuation

Medico Remedies Limited carries a market capitalization of 3.37B, placing it among publicly traded companies globally. Its enterprise value stands at 2.85B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap3.37B
Enterprise Value2.85B

Share Statistics

Medico Remedies Limited currently has 82.98M shares outstanding.

Shares Outstanding82.98M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Medico Remedies Limited trades at a trailing price-to-earnings ratio of 20.53. The price-to-sales ratio is 1.30, and the price-to-book ratio stands at 16.23.

PE Ratio20.53
PS Ratio1.30
PB Ratio16.23
P/TBV Ratio3.57
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Medico Remedies Limited trades at an EV/EBITDA multiple of 20.44 and an EV/FCF ratio of 217.08. The EV/Sales ratio of 1.38 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 20.44 provides insight into valuation relative to core operating earnings.

EV / Sales1.38
EV / EBITDA20.44
EV / EBIT20.44
EV / FCF217.08

Financial Position

Medico Remedies Limited maintains a current ratio of 1.66, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 25.44, indicating elevated leverage, while an interest coverage ratio of 7.71 demonstrates adequate ability to service its debt obligations.

Current Ratio1.66
Quick Ratio0.05
Debt / Equity25.44
Debt / EBITDA1.38
Interest Coverage7.71

Financial Efficiency

Medico Remedies Limited posts a return on equity of 34.75 and a return on invested capital of 11.49.

Return on Equity (ROE)34.75
Return on Assets (ROA)9.60
Return on Invested Capital (ROIC)11.49
Return on Capital Employed (ROCE)26.38
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover5.33

Taxes

Over the trailing twelve months, Medico Remedies Limited has paid 49.44M in income taxes, reflecting an effective tax rate of 27.38.

Income Tax49.44M
Effective Tax Rate27.38

Stock Price Statistics

Medico Remedies Limited's stock has declined approximately -3.21112% over the past 52 weeks. The 50-day moving average sits at 43.35, while the 200-day moving average is 45.98.

Beta (5Y)N/A
52-Week Price Change-3.21112%
50-Day Moving Average43.35
200-Day Moving Average45.98
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Medico Remedies Limited generated 2.06B in revenue and converted that into 131.15M in net income, yielding earnings per share of 1.59. EBITDA reached 139.33M, while operating income came in at 139.33M.

Revenue2.06B
Gross Profit550.50M
Operating Income139.33M
Pretax Income180.60M
Net Income131.15M
EBITDA139.33M
EBIT139.33M
Earnings Per Share (EPS)1.59

Balance Sheet

Medico Remedies Limited holds 37.56M in cash and equivalents against 192.04M in total debt, resulting in a net debt position of 169.28M. Total book value stands at 165.97M, with working capital of 512.75M providing operational flexibility.

Cash & Cash Equivalents37.56M
Total Debt192.04M
Net Debt169.28M
Equity (Book Value)165.97M
Book Value Per Share2.01
Working Capital512.75M

Margins

Medico Remedies Limited operates with a gross margin of 26.67, reflecting its pricing power and cost economics. The operating margin of 6.75 and net profit margin of 6.36 provide insight into operational efficiency.

Gross Margin26.67
Operating Margin6.75
Pretax Margin8.75
Profit Margin6.36
EBITDA Margin6.75

Stock Splits

Medico Remedies Limited's most recent stock split took place on March 16, 2023 with a 1:5 split ratio.

Last Split Date3/16/2023
Split Ratio1:5

Scores

Medico Remedies Limited posts an Altman Z-Score of 4.12, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.12